Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients

Little is known about outcomes of patients with chronic lymphocytic leukemia (CLL) with del(17p13.1) karyotype at diagnosis. We reviewed 114 de novo del(17p13.1) CLL patients seen at our institution. Using proportional hazards models to identify pretreatment clinical variables significantly associat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Hematol
Asıl Yazarlar: Stephens, Deborah M., Ruppert, Amy S., Weirda, William G., Jones, Jeffrey A., Woyach, Jennifer A., Maddocks, Kami, Jaglowski, Samantha M., Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Tam, Constantine, O’Brien, Susan, Keating, Michael J., Muthusamy, Natarajan, Abruzzo, Lynne V., Heerema, Nyla A., Byrd, John C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055503/
https://ncbi.nlm.nih.gov/pubmed/26202978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24125
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller